ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 45.88%
This Quarter Est. Return
1 Year Est. Return
+45.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$188M
AUM Growth
+$22M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$15.7M
2
+$13.5M
3
+$12.8M
4
IQV icon
IQVIA
IQV
+$12.5M
5
CNC icon
Centene
CNC
+$12.2M

Top Sells

1
+$11.5M
2
+$10.5M
3
+$10.4M
4
HOLX icon
Hologic
HOLX
+$10.3M
5
SAGE
Sage Therapeutics
SAGE
+$10.2M

Sector Composition

1 Healthcare 99.63%
2 Financials 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
1
BioMarin Pharmaceuticals
BMRN
$10.2B
$15.7M 8.34%
+177,741
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$14.8M 7.87%
137,610
+112,661
UNH icon
3
UnitedHealth
UNH
$323B
$13.5M 7.16%
+26,844
ABBV icon
4
AbbVie
ABBV
$401B
$12.8M 6.79%
+94,448
IQV icon
5
IQVIA
IQV
$35B
$12.5M 6.64%
+44,314
CNC icon
6
Centene
CNC
$17.5B
$12.2M 6.48%
+148,254
BLU
7
DELISTED
BELLUS Health Inc.
BLU
$10.3M 5.47%
1,280,757
+208,059
CYTK icon
8
Cytokinetics
CYTK
$7.05B
$10.3M 5.45%
225,032
-21,304
JNJ icon
9
Johnson & Johnson
JNJ
$463B
$9.54M 5.06%
+55,755
NTRA icon
10
Natera
NTRA
$24.8B
$9.49M 5.04%
+101,674
FOLD icon
11
Amicus Therapeutics
FOLD
$2.5B
$8.28M 4.39%
716,709
+62,733
ARGX icon
12
argenx
ARGX
$51.6B
$7.31M 3.88%
+20,881
KURA icon
13
Kura Oncology
KURA
$879M
$7.03M 3.73%
502,275
+307,966
APLS icon
14
Apellis Pharmaceuticals
APLS
$3.05B
$6.59M 3.5%
+139,445
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$6.44M 3.42%
43,876
+1,885
ISEE
16
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$6.29M 3.34%
375,989
+20,593
QTRX icon
17
Quanterix
QTRX
$276M
$6.07M 3.22%
143,204
-18,729
ITOS
18
DELISTED
iTeos Therapeutics
ITOS
$4.88M 2.59%
104,755
+47,469
DICE
19
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$4.69M 2.49%
185,201
-89,964
AVDL
20
Avadel Pharmaceuticals
AVDL
$1.46B
$2.98M 1.58%
369,134
-105,234
ACRS icon
21
Aclaris Therapeutics
ACRS
$222M
$2.89M 1.53%
198,493
-43,208
PMVP icon
22
PMV Pharmaceuticals
PMVP
$76.3M
$2.26M 1.2%
97,680
-3,202
RGLS
23
DELISTED
Regulus Therapeutics
RGLS
$860K 0.46%
273,104
+132,955
BLSA
24
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$699K 0.37%
71,372
-1,934
ALKS icon
25
Alkermes
ALKS
$5.08B
– –
-373,382
1
2